Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Durez

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Rheumatology and Therapy|February 8, 2022
Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels CohortXavier Theunssens, Laura Bricman, Stéphanie Dierckx, et al.
Diagnostic and Interventional Imaging|March 30, 2023
Comparison between 2D FSE T2-weighted Dixon MRI and contrast-enhanced 2D FSE and 3D FSPGR T1-weighted Dixon MRI to quantify inflammation in hands of patients with early rheumatoid arthritisBrice Dion, Romain Lacrosse, Nicolas Michoux, et al.
Diagnostic and Interventional Imaging|October 20, 2021
India ink artifact on Dixon out-of-phase images can be used as a landmark to measure joint space width at MRIThomas Kirchgesner, Anas El Kassimy, Nicolas Michoux, et al.
RMD Open|March 13, 2026
Autoantibody biomarkers and first-line therapy response in RA: findings from the CAP48 cohortSukayna Fadlallah, Judith Fraussen, Pieter Ruytinx, et al.
Rheumatology (Oxford, England)|February 19, 2021
Should we use glucocorticoids in early rheumatoid arthritis? Results at 5 years from the early RA UCLouvain Brussels cohortEmilie Sapart, Tatiana Sokolova, Stéphanie de Montjoye, et al.
Arthritis Research & Therapy|September 14, 2010
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategiesBert Vander Cruyssen, Patrick Durez, Rene Westhovens, et al.
Acta Clinica Belgica|September 16, 2020
Treatment innovation for patients: a collaborative network in the Benelux and an inside view of 20 years of GalapagosPatrick Durez, André Hoekema, Tom Huizinga, et al.
Rheumatology (Oxford, England)|November 17, 2021
Human carbamylome description identifies carbamylated α2-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritisPaschalis Sidiras, Jessica Lechanteur, Virginie Imbault, et al.
Plos One|November 29, 2016
A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise StudySophie De Mits, Jan Lenaerts, Bert Vander Cruyssen, et al.
Seminars in Arthritis and Rheumatism|August 14, 2024
Analysis of synovitis patterns in early RA supports the importance of joint-specific factorsLaura Bricman, Clément Triaille, Emilie Sapart, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Rheumatology and Therapy|February 8, 2022
Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels CohortXavier Theunssens, Laura Bricman, Stéphanie Dierckx, et al.
Diagnostic and Interventional Imaging|March 30, 2023
Comparison between 2D FSE T2-weighted Dixon MRI and contrast-enhanced 2D FSE and 3D FSPGR T1-weighted Dixon MRI to quantify inflammation in hands of patients with early rheumatoid arthritisBrice Dion, Romain Lacrosse, Nicolas Michoux, et al.
Diagnostic and Interventional Imaging|October 20, 2021
India ink artifact on Dixon out-of-phase images can be used as a landmark to measure joint space width at MRIThomas Kirchgesner, Anas El Kassimy, Nicolas Michoux, et al.
RMD Open|March 13, 2026
Autoantibody biomarkers and first-line therapy response in RA: findings from the CAP48 cohortSukayna Fadlallah, Judith Fraussen, Pieter Ruytinx, et al.
Rheumatology (Oxford, England)|February 19, 2021
Should we use glucocorticoids in early rheumatoid arthritis? Results at 5 years from the early RA UCLouvain Brussels cohortEmilie Sapart, Tatiana Sokolova, Stéphanie de Montjoye, et al.
Arthritis Research & Therapy|September 14, 2010
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategiesBert Vander Cruyssen, Patrick Durez, Rene Westhovens, et al.
Acta Clinica Belgica|September 16, 2020
Treatment innovation for patients: a collaborative network in the Benelux and an inside view of 20 years of GalapagosPatrick Durez, André Hoekema, Tom Huizinga, et al.
Rheumatology (Oxford, England)|November 17, 2021
Human carbamylome description identifies carbamylated α2-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritisPaschalis Sidiras, Jessica Lechanteur, Virginie Imbault, et al.
Plos One|November 29, 2016
A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise StudySophie De Mits, Jan Lenaerts, Bert Vander Cruyssen, et al.
Seminars in Arthritis and Rheumatism|August 14, 2024
Analysis of synovitis patterns in early RA supports the importance of joint-specific factorsLaura Bricman, Clément Triaille, Emilie Sapart, et al.
Pageof 12